Daytrana (methylphenidate transdermal system)
Defective Delivery System: Out of specification for mechanical peel and shear.
Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.
14,543 recalls, newest first.
Defective Delivery System: Out of specification for mechanical peel and shear.
Defective Delivery System: Out of specification for mechanical peel and shear.
Defective Delivery System: Out of specification for mechanical peel and shear.
Defective Delivery System: Out of specification for mechanical peel and shear.
Product Mix-Up: A foreign tablet was found in bottle.
cGMP Deviation
Lack of Assurance of Sterility--Reports of loose metal ferrule crimps on vials for injection. The entire cap either lifted or dislodged while attempting to flip off the orange color plastic button.
Lack Of Processing Controls
Lack Of Processing Controls
Lack Of Processing Controls
Lack Of Processing Controls
Lack Of Processing Controls
Lack Of Processing Controls
Failed Dissolution Specifications: Low out of specification dissolution result observed during stability testing.
Failed Impurities/Degradation Specification; high out of specification results observed
Failed Dissolution Specifications: Low out of specification results observed in dissolution test at six-month long-term stability study.
Presence of Foreign Substance: Customer complaint of a foreign substance identified as nylon cable tie
GMP Deviations: Product bottle may be absent of desiccant.
GMP Deviations: Product bottle may be absent of desiccant.
Defective Container: products potentially could have been packaged in defective bottles, with a notched rim, that could cause inadequate foil sealing resulting in lack of moisture protection.
Defective Container: products potentially could have been packaged in defective bottles, with a notched rim, that could cause inadequate foil sealing resulting in lack of moisture protection.
Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle.
Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle.
Defective Container: confirmed customer reports for vials with loose metal overseal crimp defects, which may result in lack of assurance of sterility.
Microbial Contamination of Non-Sterile Products